To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Detroit Free Press
Karmanos’ new president and CEO, Boris Pasche, M.D., Ph.D., FACP, is the co-inventor of the TheraBionic P1 device. This medical device received FDA approval in 2023 for the treatment of advanced hepatocellular carcinoma for patients who failed first- and second-line treatments. Karmanos will be the first cancer center to offer the device to patients in 2024. Dr. Pasche and Anthony Shields, M.D., Ph.D., medical oncologist and leader of the Gastrointestinal and Neuroendocrine Oncology and the Phase 1 Clinical Trials Multidisciplinary Teams, explain how the device works to stop tumor growth.
Read the article here.
Boris Pasche, M.D., Ph.D., FACP
Anthony Shields, M.D., Ph.D.